1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6867C993F015C8C99002585A50034AF0D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/SearchNew?OpenForm&Query=(strategic%20planning)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&ItemCatalog=BMR&SearchOrder=1&Start=1&Count=10
18
19OpenForm&Query=(strategic%20planning)%20and%20(field%20ItemCatalog%3DBMR)&SearchWV=1&ItemCatalog=BMR&SearchOrder=1&Start=1&Count=10
203.236.8.46
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25BMR




Search Results

Results 1 - 10 of 106 Total Hits, Sorted by Relevance.

    |    

Resource Benchmarks for Global Pharmaceutical Marketing ServicesDirect access to this research is not included with your membership level.This is a pharma specific study.This document contains Metrics and a practice summary Matrix.This document contains Metrics and a practice summary Matrix.

Effective staffing of key marketing services functions is critical to pharmaceutical brand recognition and success... (ID PSM-291)
Companies Profiled: Abdi Ibrahim Pharmaceuticals, Upsher-Smith, Novartis, Kerr Health, more ...

Optimizing Oncology Market Research & AnalyticsDirect access to this research is not included with your membership level.

Market research and analytics organizations play a vital role in providing oncology brand teams with the information they need to make better decisions, quicker... (ID PSM-217)
Companies Profiled: Novartis, Genmab, Human Genome Sciences, Eli Lilly and Company, more ...

Best Practices in Utilizing Health Outcomes DataDirect access to this research is not included with your membership level.

Optimizing the use of Health Outcomes data is vital to the success of biotechnology and pharmaceutical companies... (ID PSM-236)
Companies Profiled: Abbott, Alfred Mann Foundation, ASSESSmint, Baxter, more ...

Pharmaceutical New Product Planning Excellence: Structure & Activities that Drive Profitability & GrowthDirect access to this research is not included with your membership level.

Bio-pharmaceutical organizations are under intense pressure to deliver innovative new products in shorter time frames while minimizing development costs... (ID PSM-333)
Companies Profiled: Alkermes, Allergan, Astellas, Bayer, more ...

Maximizing the Impact of Medical Affairs in Hematology Product LaunchesDirect access to this research is not included with your membership level.

Biopharma manufacturers seeking to differentiate their hematological therapies at launch are increasingly turning to their own medical experts... (ID POP-323)
Companies Profiled: AbbVie, Celgene, Crescendo Bioscience, Curis, more ...

Maximizing the Impact of Medical Affairs in Oncology Product LaunchesDirect access to this research is not included with your membership level.

The rapid pace of innovation in oncology therapeutics has led to intense competition between pharma companies to successfully launch their new products into the market... (ID POP-322)
Companies Profiled: AbbVie, Alkermes, AstraZeneca, Boehringer Ingelheim, more ...

Maximizing the Impact of Medical Affairs in Product LaunchDirect access to this research is not included with your membership level.

In the past decade, Medical Affairs has significantly evolved to play a critical role in launch success... (ID POP-311)
Companies Profiled: AbbVie, AcelRx, Alcon Laboratories, Alkermes, more ...

Identifying Superior Corporate Affairs and Corporate Communications CapabilitiesDirect access to this research is not included with your membership level.

The Corporate Affairs or Corporate Communications function serves a wide-ranging role in an organization, from maintaining company and brand reputati... (ID PSM-347)
Companies Profiled: Amgen, Bayer, GlaxoSmithKline , Johnson & Johnson, more ...

Big Data in Pharma: Current & Future Trends for Big Data Utilization Across Commercial FunctionsDirect access to this research is not included with your membership level.

The last decade has seen an explosion in the availability of data that can deliver valuable insights for key commercial decisions within the biopharm... (ID PSM-315)
Companies Profiled: AstraZeneca, Genentech, Baxter BioScience, GlaxoSmithKline , more ...

Big Data in Pharma: Current & Future Trends for Big Data Utilization Across Medical Affairs FunctionsDirect access to this research is not included with your membership level.

The biopharmaceutical industry has seen an explosion in the availability of big data that can generate valuable insights for the Medical Affairs function... (ID PSM-316)
Companies Profiled: AstraZeneca, Novartis, Janssen, Esteve, more ...